The role of IL-6 in the inflammatory and humoral response to adenoviral vectors

Journal of Gene Medicine

Volumn 2, Issue 3, 2000, Pages 194-203

  Benihoud, Karim ^b   Salone, Barbara ^a   Esselin, Stephanie ^b   Opolon, Paule ^b   Poli, Valeria ^c   Di Giovine, Monica ^a,d   Perricaudet, Michel ^b   Saggio, Isabella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Lab Vectorologie Transfert de Genes   (France)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Acute phase proteins; Adenovirus; Immune response; Inflammation; Interleukin 6

Indexed keywords

ADENOVIRIDAE; ANIMALIA;

ACUTE PHASE PROTEIN; INTERLEUKIN 6;

ADENOVIRUS; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ACUTE-PHASE PROTEINS; ADENOVIRIDAE; ANIMALS; ANTIBODY FORMATION; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-6; MICE; MICE, KNOCKOUT;

EID: 0034184767     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-2254(200005/06)2:3<194::AID-JGM102>3.0.CO;2-5     Document Type: Article

References (43)

1. Hitt MM, Addison CL, Graham FL. Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 1997; 40: 137-206.
2. Kremer E, Perricaudet M. Adenovirus and adeno-associated virus mediated gene tansfer. Br Med Bull 1995; 51: 31-44.
3. Kovesdi I, Brough DE, Bruder JT, Wickham TJ. Adenoviral vectors for gene transfer. Curr Opin Biotechnol 1997; 8: 583-589.
4. Ginsberg HS, Moldawer LL, Sehgal PB, et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci U S A 1991; 88: 1651-1655.
5. Wolff G, Worgall S, van Rooijen N, Song WR, Harvey BG, Crystal RG. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 1997; 1997: 624-629.
6. Lieber A, He CY, Meuse L, et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 1997; 71: 8798-8807.
7. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
8. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 1996; 273: 1862-1864.
9. Yang Y, Su Q, Grewal IS, Schilz R, Flavell R, Wilson JM. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J Virol 1996; 70: 6370-6377.
10. Yang Y, Nunes FA, Berencsi K, Goumlnczoumll, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 1994; 91: 4407-4411.
11. Wadsworth SC, Zhou H, Smith AE, Kaplan JM. Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic t-lymphocyte killing in vivo. J Virol 1997; 71: 5189-5196.
12. Tripathy SK, Black HB, Goldwasser E, Leiden J. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 1996; 2: 545-550.
13. Yang Y, Joos KU, Su Q, Ertl HCJ, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther 1996; 3: 137-144.
14. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1995; 1: 890-893.
15. Kishimoto T, Akira S, Nazaraki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995; 86: 1243-1254.
16. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81-88.
17. Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response in interleukin-6-deficient mice. J Exp Med 1994; 180: 1243-1250.
18. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1-78.
19. Romani L, Mencacci A, Cenci E, et al. Impaired neutrophil response and cd4+ t helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1345-1355.
20. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-342.
21. McElvaney N, Crystal RG. IL-6 release and air-way administration of human CFTR cDNA adenovirus vector. Nat Med 1995; 1: 182-184.
22. Crystal RG, Mc Elvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51
23. Spergel J, Chen-Kiang S. Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation. Proc Natl Acad Sci U S A 1991; 88: 6472-6476.
24. Spergel JM, Hsu W, Akira S, Thimmappaya B, Kishimoto T, Chen-Kiang S. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A. J Virol 1992; 66: 1021-1030.
25. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994; 13: 1180-1189.
26. Ramsay AJ, Husband AJ, Ramshaw IA, et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994; 264: 561-563.
27. Lan Tran P, Weinbach J, Opolon P, et al. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. J Clin Invest 1997; 99: 608-617.
28. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
29. 1-antitrypsin using a recombinant adenovirus vector. FEBS LETT 1990; 267: 60-62.
30. Thimmappaya B, Weinberger C, Schneider RJ, Shenk T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 1982; 31: 543-551.
31. Fallaux FJ, Kranenburg O, Cramer SJ, et al. Characterization of 911: a new helper cell line for the titration and propagation of early-region-1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215-222.
32. Michalski JP, McCombs CC, Sheth S, McCarthy M, deShazo R. A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. J Immunol Methods 1985; 83: 101-112.
33. Dedieu J-F, Vigne E, Torrent C, et al. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J Virol 1997; 71: 4626-4637.
34. Mortensen RF, Shapiro J, Lin B, Douches S, Neta R. Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of acute phase proteins. J Immunol 1988; 140: 2260-2266.
35. Huard J, Lochmuller H, Ascadi G, Jani A, Massie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995; 2: 107-115.
36. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4+ T cells. J Exp Med 1997; 185: 461-470.
37. Michou AI, Santoro L, Christ M, Juillard V, Pavirani A, Methali M. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther 1997; 4: 473-482.
38. Ilan Y, Droguetti G, Chowdhury NR, et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune response and permits long-term gene expression. Proc Natl Acad Sci U S A 1997; 94: 2587-2592.
39. Elkon KB, Liu C-C, Gall JG, et al. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc Natl Acad Sci U S A 1997; 94: 9814-9819.
40. Benihoud K, Saggio I, Opolon P, et al. Efficient repeated adenovirus readministration in TNFα/LTα deficient mice. J Virol 1998; 72: 9514-9525.
41. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-113.
42. McCoy RD, Davidson BL, J. RB, et al. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum Gene Ther 1995; 6: 1553-1560.
43. Starnes HFJ, Pearce MK, Tewari A, Yim JH, Zou JC, Abrams JS.Anti-IL6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J Immunol 1990; 145: 4185-4191.